For people living with type 2 diabetes who need insulin, treatment focuses on keeping blood sugar levels within a healthy range to prevent serious health problems affecting the heart, kidneys, eyes, and nerves. The choice of insulin therapy depends on how well the body responds to other treatments, and doctors work closely with patients to find the right approach that fits their daily life.

Managing Diabetes When Tablets Are Not Enough

When someone receives a diagnosis of type 2 diabetes, the first line of treatment usually involves lifestyle changes and oral medications. These tablets work by helping the body use its own insulin more effectively or by encouraging the pancreas to produce more of this vital hormone. However, type 2 diabetes is a condition that changes over time. Research shows that the cells in the pancreas that make insulin gradually lose their ability to function, declining at roughly four percent each year.^[4] This means that what works well at diagnosis may not be sufficient years later.

The moment when insulin becomes necessary is not a sign of personal failure or poor diabetes management. It simply reflects the natural progression of the condition. Some people might need insulin temporarily during periods of illness, pregnancy, or after surgery when blood sugar becomes harder to control. Others will require it as a long-term addition to their treatment plan when oral medications alone can no longer keep blood sugar in the target range.^[7]

Medical guidelines suggest considering insulin therapy when the A1C level (a measure of average blood sugar over the past two to three months) rises above nine percent, especially if someone experiences symptoms like excessive thirst, frequent urination, or unexplained weight loss. Insulin may also be added when A1C remains above eight percent despite taking two oral medications.^[4] By the time most people are diagnosed with type 2 diabetes, up to half of their insulin-producing cells are already not working properly.^[4]

Standard Treatment With Insulin

When doctors prescribe insulin for type 2 diabetes, they typically start with one of several approaches, depending on the individual’s current blood sugar levels and overall health situation. The goal is to mimic the body’s natural insulin production as closely as possible while keeping the treatment manageable in daily life.

Types of Insulin Used

For people with type 2 diabetes, the most common starting point is long-acting or intermediate-acting insulin. These types work throughout the day or night to keep blood sugar steady between meals and during sleep. Long-acting insulin formulations include brands like Lantus, Levemir, Toujeo, Tresiba, Semglee, and Abasaglar. Intermediate-acting options include Humulin I and Insulatard, which are typically taken once or twice daily.^[7]

Long-acting insulin is often recommended for people who experience frequent episodes of hypoglycemia (dangerously low blood sugar) or who need assistance from a caregiver to manage their injections. This type of insulin provides a steady, predictable effect over twenty-four hours, reducing the risk of blood sugar dropping too low.^[7]

If long-acting or intermediate-acting insulin alone does not bring A1C levels down to target, doctors may add rapid-acting or short-acting insulin to be taken before meals. These insulins work quickly to cover the spike in blood sugar that happens after eating. Rapid-acting brands include NovoRapid, Fiasp, Trurapi, Admelog, Humalog, Lyumjev, and Apidra. Short-acting options include Actrapid and Humulin S.^[7]

Another option is biphasic insulin, also called mixed insulin, which combines intermediate and rapid-acting insulin in one injection. This reduces the number of daily injections but offers less flexibility in adjusting doses. Biphasic insulin is taken before meals, one to three times per day, and includes brands like NovoMix, Humalog Mix, and Humulin M3.^[7]

How Insulin Dosing Works

Insulin therapy can be started in two ways. Augmentation therapy means adding insulin to existing oral medications to give extra support, typically starting at a dose of 0.3 units per kilogram of body weight. Replacement therapy means using insulin as the primary treatment, starting at 0.6 to 1.0 units per kilogram. In replacement therapy, half of the daily insulin dose is given as basal (background) insulin, and the other half is divided among meals as bolus (mealtime) insulin.^[4]

Doctors adjust insulin doses every three to four days based on self-monitored blood sugar readings. The target is typically a fasting and pre-meal blood sugar of 80 to 130 milligrams per deciliter, and less than 180 milligrams per deciliter two hours after eating.^[4] Fasting glucose readings guide adjustments to basal insulin, while pre-meal and post-meal readings guide adjustments to mealtime insulin.^[4]

Combining Insulin With Other Medications

Most people with type 2 diabetes continue taking their oral medications when starting insulin, rather than stopping them abruptly. This combination approach often works better than insulin alone. Research shows that continuing metformin alongside insulin is particularly beneficial. Metformin is proven to reduce overall mortality and cardiovascular events in people with diabetes who are overweight. The combination also leads to less weight gain, lower insulin doses, and fewer episodes of hypoglycemia compared to insulin used by itself.^[4]

Stopping oral medications suddenly when starting insulin can cause blood sugar to rebound and rise again, which is why doctors recommend maintaining these treatments unless there is a specific reason to discontinue them.^[4]

How Insulin Is Taken

Insulin must be injected because it is a protein that would be broken down by stomach acids if swallowed. The most common methods include syringes and needles, insulin pens, and insulin pumps. Modern needles are very small and thin, and most people find that injections cause minimal discomfort. The insulin is injected just under the skin, typically in the abdomen, thighs, buttocks, or upper arms.^[6]

Diabetes nurses provide training on injection technique, proper injection sites, and how to rotate sites to avoid tissue changes that can affect insulin absorption. Injecting repeatedly in the same spot can cause lipohypertrophy, a thickening of fatty tissue that interferes with insulin absorption and can lead to unpredictable blood sugar levels.^[4]

Potential Side Effects and Concerns

The main side effects of insulin therapy are hypoglycemia and weight gain. Hypoglycemia occurs when blood sugar drops below 70 milligrams per deciliter. Symptoms include shakiness, sweating, confusion, rapid heartbeat, and hunger. Severe hypoglycemia can lead to loss of consciousness and requires immediate treatment with fast-acting carbohydrates like juice or glucose tablets. Research has linked repeated hypoglycemia to increased risk of dementia and heart rhythm problems, so managing this risk is an important part of treatment.^[4]

Weight gain with insulin therapy happens because insulin promotes storage of glucose and calories, increases appetite, and can lead to “defensive eating” where people consume extra food to prevent low blood sugar. In one large study, people with type 2 diabetes taking insulin gained an average of four kilograms, though this was associated with improved blood sugar control.^[4]

Studies comparing different insulin regimens found that premixed and bolus insulin were associated with more hypoglycemia episodes, while bolus insulin caused more weight gain.^[4] Newer insulin formulations called analogues have been shown to cause less post-meal blood sugar spikes and delayed hypoglycemia compared to older human insulin, though they work equally well at lowering A1C levels.^[4]

Pain from injections and blood sugar monitoring can be a concern, though newer equipment with thinner needles has helped reduce discomfort significantly.^[4]

Duration of Therapy

For most people with type 2 diabetes, insulin therapy is a long-term treatment. However, some individuals may only need insulin temporarily. For example, insulin might be prescribed during pregnancy to protect both mother and baby, during illness when blood sugar becomes difficult to manage, or when first diagnosed with very high blood sugar levels that need rapid correction.^[7] Once the temporary situation resolves, some people can return to managing their diabetes with oral medications and lifestyle changes alone.

Treatment in Clinical Trials

While standard insulin therapy has been the backbone of treatment for decades, researchers continue to explore new approaches to improve outcomes for people with type 2 diabetes who require insulin. The focus is on developing insulins that work more like the body’s natural insulin, reducing side effects like hypoglycemia and weight gain, and creating treatment combinations that address multiple aspects of diabetes at once.

Newer Insulin Formulations

Recent years have seen the approval of several new insulin formulations designed to provide better blood sugar control with fewer complications. These newer insulins, often called insulin analogues, are modified versions of human insulin that have been chemically adjusted to change how quickly they act and how long they last in the body. Studies show that these analogues are as effective as older human insulin at lowering A1C levels, but they tend to cause less hypoglycemia, particularly during the night and several hours after meals.^[4]

The development of ultra-long-acting insulins represents a significant advancement. These formulations can maintain stable blood sugar levels for more than twenty-four hours with a single injection, offering more flexibility in when people take their dose and providing more consistent blood sugar control throughout the day and night. This can be particularly helpful for people whose schedules vary or who have difficulty remembering to take medication at the same time each day.

Biosimilar Insulins

Another area of development involves biosimilar insulins. These are versions of already-approved insulin products that are highly similar in structure and function but are made by different manufacturers. Biosimilars offer the same clinical benefits as the original insulin but typically at lower cost, making treatment more accessible to more people. Regulatory agencies carefully review biosimilars to ensure they meet strict standards for safety and effectiveness before approval.

Combination Approaches Under Investigation

Researchers are actively studying how insulin can be combined with other classes of diabetes medications to maximize benefits while minimizing side effects. For instance, trials are examining the use of insulin together with GLP-1 receptor agonists, medications that stimulate insulin release in response to food, slow stomach emptying, and promote feelings of fullness. This combination has shown promise in helping people achieve better blood sugar control with lower insulin doses and less weight gain.

Studies are also investigating the optimal timing for adding insulin to treatment plans. Evidence suggests that many people could benefit from starting insulin earlier in their disease course rather than waiting until blood sugar is severely elevated. Trials are working to identify which patients would most benefit from early insulin initiation and which could continue with other treatments for longer periods.

Understanding Trial Phases

Clinical trials for insulin and diabetes treatments typically progress through several phases. Phase I trials focus on safety, testing new treatments in small groups of volunteers to understand how the body processes the medication and identify any immediate side effects. Phase II trials expand to larger groups of people with diabetes to evaluate whether the treatment effectively lowers blood sugar and continues to be safe. Phase III trials involve hundreds or thousands of participants and compare the new treatment directly against current standard treatments to determine if it offers advantages in effectiveness, safety, or quality of life.

Emerging Technologies

Beyond new insulin formulations themselves, research continues on improved delivery methods. Investigations into inhaled insulin, insulin patches, and smart insulin delivery systems that automatically adjust doses based on continuous blood sugar readings are ongoing. These technologies aim to make insulin therapy more convenient and more closely mimic the body’s natural insulin response.

Researchers are also studying ways to protect and restore the insulin-producing cells in the pancreas, though this work is still in early stages for type 2 diabetes. Understanding the mechanisms behind beta cell failure could eventually lead to treatments that slow or reverse this process, potentially reducing or eliminating the need for insulin therapy in some individuals.

Global Research Efforts

Clinical trials for insulin therapy in type 2 diabetes take place worldwide, including in the United States, Europe, and many other regions. Different populations may respond differently to treatments due to genetic, dietary, and lifestyle factors, making international research important for developing approaches that work for diverse groups of people. People interested in participating in trials can discuss opportunities with their healthcare providers or search clinical trial registries to find studies accepting participants in their area.

Most common treatment methods

• Basal insulin therapy
  • Long-acting insulins (Lantus, Levemir, Toujeo, Tresiba, Semglee, Abasaglar) taken once daily to provide steady background insulin levels
  • Intermediate-acting insulins (Humulin I, Insulatard) taken once or twice daily
  • Usually the first type of insulin added to oral medications when tablets alone are insufficient
  • Started at doses of approximately 0.3 units per kilogram of body weight for augmentation therapy
• Mealtime (bolus) insulin therapy
  • Rapid-acting insulins (NovoRapid, Fiasp, Trurapi, Admelog, Humalog, Lyumjev, Apidra) taken immediately before meals
  • Short-acting insulins (Actrapid, Humulin S) taken before meals
  • Added when basal insulin alone does not achieve blood sugar targets
  • Doses adjusted based on carbohydrate intake and blood sugar readings
• Mixed (biphasic) insulin therapy
  • Premixed formulations (NovoMix, Humalog Mix, Humulin M3) combining intermediate and rapid-acting insulin
  • Taken one to three times daily before meals
  • Reduces number of daily injections but offers less dosing flexibility
• Combination therapy with oral medications
  • Metformin continued alongside insulin to reduce insulin doses, minimize weight gain, and decrease cardiovascular risk
  • Other oral medications often maintained unless contraindicated
  • Prevents rebound hyperglycemia that can occur when oral medications are stopped abruptly
• Insulin analogues
  • Chemically modified versions of human insulin designed for improved absorption and action
  • Associated with lower risk of hypoglycemia, particularly nocturnal and delayed hypoglycemia
  • Similar A1C-lowering effectiveness compared to human insulin but with better safety profile

Managing Life With Insulin Therapy

Starting insulin therapy represents a significant adjustment in daily routine, but with proper education and support, most people adapt successfully. Diabetes self-management education programs provide training on injection techniques, blood sugar monitoring, recognizing and treating hypoglycemia, proper insulin storage, and integrating insulin therapy into work, travel, and social activities.

Regular blood sugar monitoring becomes even more important when taking insulin. Keeping records of blood sugar readings, insulin doses, meals, and physical activity helps identify patterns and guides dose adjustments. Many people use electronic devices or smartphone apps to track this information, making it easier to spot trends and share data with healthcare providers.

Insulin must be stored properly to maintain its effectiveness. Unopened insulin should be refrigerated, while insulin currently in use can typically be kept at room temperature for a specified period, usually up to twenty-eight days depending on the formulation. Insulin should never be frozen or exposed to extreme heat, as this can damage the medication.

Support from healthcare teams is essential for successful insulin therapy. Regular check-ups allow doctors to review blood sugar records, adjust insulin doses, screen for diabetes complications, and address concerns. Many healthcare systems offer access to diabetes educators, dietitians, and mental health professionals who specialize in helping people manage the emotional and practical challenges of living with diabetes requiring insulin.